Protected Coronary Arteries Do Open Grafts Pave the Way to Survival?∗ by Bittencourt, Márcio Sommer & Hulten, Edward
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 6 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 4 . 0 4 . 0 0 8E D I T O R I A L C OMM E N T
Protected Coronary Arteries
Do Open Grafts Pave the Way to Survival?*Márcio Sommer Bittencourt, MD, MPH,y Edward Hulten, MD, MPHzx
São Paulo, Brazil; Kandahar, Afghanistan; and Bethesda, MarylandAlthough considerable discussion has recently
permeated the use of coronary artery bypass grafts
(CABG) for the initial treatment of stable coronary
artery disease (CAD), CABG is currently consid-
ered a Class I indication to improve survival in in-
dividuals with unprotected left main coronary artery
obstruction and 2- or 3-vessel disease with proximal
left anterior descending coronary artery disease, as
well as to improve symptoms in individuals with
signiﬁcant stenosis amenable to revascularizationSee page 580with unacceptable angina despite medical therapy
(1). Still, the long-term efﬁcacy of the surgical
procedure is hindered both by the progression of
native vessel CAD and by chronic graft failure (2).
Fifteen percent of saphenous vein grafts occlude
during the ﬁrst post-operative year, and up to 1 in
every 2 patients will develop failure of at least 1
venous graft in the longer term. Furthermore, 15%
of left internal mammary artery grafts occlude after
10 years (3). Given that more than 1 CABG pro-
cedure is performed per 1,000 U.S. adults per year
(4), the clinical and socioeconomic impact of those
late CABG complications should not be under-
estimated. Some studies have previously tried to*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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gression to better understand the impact of those
ﬁndings on clinical outcomes.
A classic study by Lytle et al. (5), including more
than 1,000 individuals in a retrospective cohort with
a mean follow-up of 83 months, demonstrated that
among various predictors, stenosis of the vein graft
to the left anterior descending coronary artery was
associated with a worse prognosis, whereas grafts to
other vessels were not. Another analysis restricted
to early (<18 months after CABG) graft failure
demonstrated that even nonobstructive early graft
failure was a strong predictor of long-term outcomes
(6). Nonetheless, a more recent study, including
1,829 individuals who underwent routine invasive
angiography after CABG and were followed for a
shorter term of 18 months, was unable to detect a
signiﬁcant increase in the hazard risk for cardio-
vascular (CV) death or myocardial infarction (MI) in
individuals with graft failure (7).
Because of the potential risk associated with
invasive procedures, several studies have evaluated
the role of noninvasive stress imaging tests to stratify
risk in this population. A study using thallium-
exercise testing on 873 asymptomatic individuals
who underwent CABG demonstrated that the
detection of any perfusion defect was associated with
a 2-fold increase in the risk of death or MI (8).
Similarly, a small study including 95 patients who
underwent stress echocardiography revealed that a
low dose score, which represents the extent of viable
myocardium, was independently associated with
prognosis after CABG (9). This limited evidence
was used to support the potential indications for re-
do CABG in selected individuals according to the
American College of Cardiology/American Heart
Association 2004 Guideline Update for CABG
Surgery (10), though more recent guidelines do not
clearly address this issue.
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591More recently, 2 studies have evaluated the role
of coronary computed tomography angiography
(CTA) as a predictor of outcomes after CABG
(11,12). Those studies have developed 2 different
scores to accommodate the complexity of the
anatomic evaluation after CABG. The ﬁrst calcu-
lated the unprotected coronary territories (UCT),
whereas the second combined the number of
diseased vessels with the number of UCT. Although
both studies were limited by the short-term follow-
up of only 20 months, 1 of the studies suggested
that UCT was independently associated with an
increased rate of CV death or MI, whereas the other
suggested the combined score was a better predictor
for all-cause mortality (11,12).
In this issue of iJACC, Mushtaq et al. (13) have
made a substantial and important contribution to
the limited contemporary evidence base evaluating
the prognostic signiﬁcance of anatomic CAD after
CABG. This work provides the largest, longest
study of the value of coronary CTA to evaluate the
long-term prognosis of patients who underwent
CABG surgery. The authors should be congratu-
lated, not only for the large sample size, but also for
the impressive 98% complete follow-up of more
than 700 individuals followed for a mean of 73
months. Consistent with prior studies, the current
data clearly demonstrate that both the number of
UCT and the combination of number of diseased
vessels with the number of UCT are both strong
independent predictors of long-term outcomes in
this population. Moreover, it has also been revealed
that the more complex score was no better than the
number of UCT. On the basis of the current re-
sults, individuals with 2 or 3 UCT have, respec-
tively, an 8-fold and a 10-fold increase in the
hazard risk for future CV death or MI, after ex-
tensive adjustment for confounding. One impor-
tant aspect of the results is that even the results of
prior stress testing were included in the multivar-
iable adjustments.
A second important aspect, which should be
pointed out, is that the prevalence of any graft
disease was 26%. As expected, the prevalence of
diseased vein grafts was 37%, whereas only 9% of
the left internal mammary arteries were diseased.
Interestingly, the vast majority of the diseased seg-
ments were occluded (18%), whereas only 8% of the
grafts presented with nonocclusive disease.
Some aspects of the current analysis, however,
should be interpreted with caution. Although the
multivariable model included an extensive list of
potential confounders, the potential for residual
confounding should always be considered. Someknown confounders which were not included in
the current analysis include symptoms, indications
for coronary CTA, left ventricular function, and
chronic kidney disease. Additionally, although the
authors included the stress test results in the
model, the oversimpliﬁcation of positive versus
negative results underestimates the potential pre-
dictive value of those tests. Another important
limitation for the external validation of the current
cohort is that coronary CTA was only performed
in a selected group of post-CABG individuals
with some clinical indication for the test (symp-
toms or prior positive stress test). This selection
bias may have resulted in a higher prevalence of
graft disease and occlusion, as well as an increased
rate of events, which may not be generalizable to
other cohorts.
How can we translate the current results into
clinical practice? The easy answer is that higher-risk
individuals should be treated more aggressively,
though individuals in the post-CABG scenario
should already have been treated aggressively with
the entire CAD secondary prevention armament,
and no additional options for medical therapy
generally remain. The second, yet more important
question is whether the current results support the
use of UCT to help discuss the risk–beneﬁt ratio of
reintervention versus continued medical therapy for
patients with CAD progression post-CABG. One
might be tempted to take this even further and
consider performing screening CTA of asymptom-
atic patients after CABG, similar to a consider-
ation for physiological stress testing more than 2
years post-CABG. However, at this stage, the
current results are thought provoking with regard
to how they could inﬂuence treatment decisions,
yet they remain observational and do not evaluate
the potential beneﬁt of re-intervention. Thus,
additional studies such as propensity-matched
analysis of CABG registries or, ideally, random-
ized trials are needed to clarify better the role for
CTA after CABG. However, the high prevalence
of UCT and its impressively strong association
with CV death or MI suggest that coronary CTA
should at least be considered as part of the toolbox
for the investigation of symptoms in individuals
after CABG.Reprint requests and correspondence: Dr. Márcio Sommer
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